Human alveolar type II cells secrete and absorb liquid in response to local nucleotide signaling.
A balance sheet describing the integrated homeostasis of secretion, absorption, and surface movement of liquids on pulmonary surfaces has remained elusive. It remains unclear whether the alveolus exhibits an intra-alveolar ion/liquid transport physiology or whether it secretes ions/liquid that may communicate with airway surfaces. Studies employing isolated human alveolar type II (AT2) cells were utilized to investigate this question. Human AT2 cells exhibited both epithelial Na(+) channel-mediated Na(+) absorption and cystic fibrosis transmembrane conductance regulator-mediated Cl(-) secretion, both significantly regulated by extracellular nucleotides. In addition, we observed in normal AT2 cells an absence of cystic fibrosis transmembrane conductance regulator regulation of epithelial Na(+) channel activity and an absence of expression/activity of reported calcium-activated chloride channels (TMEM16A, Bestrophin-1, ClC2, and SLC26A9), both features strikingly different from normal airway epithelial cells. Measurements of alveolar surface liquid volume revealed that normal AT2 cells: 1) achieved an extracellular nucleotide concentration-dependent steady state alveolar surface liquid height of ∼4 μm in vitro; 2) absorbed liquid when the lumen was flooded; and 3) secreted liquid when treated with UTP or forskolin or subjected to cyclic compressive stresses mimicking tidal breathing. Collectively, our studies suggest that human AT2 cells in vitro have the capacity to absorb or secrete liquid in response to local alveolar conditions.
Bove
Peter F
PF
Department of Medicine, Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Grubb
Barbara R
BR
Okada
Seiko F
SF
Ribeiro
Carla M P
CM
Rogers
Troy D
TD
Randell
Scott H
SH
O'Neal
Wanda K
WK
Boucher
Richard C
RC
D002478:Cells, Cultured; D018118:Chloride Channels / Q000378:metabolism*; D002712:Chlorides / Q000378:metabolism*; D005576:Colforsin / Q000494:pharmacology; D006801:Humans; D011650:Pulmonary Alveoli / Q000166:cytology / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000166:cytology / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D014544:Uridine Triphosphate / Q000494:pharmacology*
D018118:Chloride Channels; D002712:Chlorides; D005576:Colforsin; D012964:Sodium; D014544:Uridine Triphosphate
J Trauma. 2003 Aug;55(2):290-7
12913640
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1301-9
19321738
Am J Physiol Lung Cell Mol Physiol. 2000 Feb;278(2):L233-8
10666105
Chest. 2007 Mar;131(3):913-920
17356114
Mol Biol Cell. 2010 Aug 1;21(15):2639-48
20554763
J Biol Chem. 2009 Mar 13;284(11):7294-306
19131335
J Clin Invest. 2002 Mar;109(5):571-7
11877463
Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L813-5
19783638
Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L104-10
14990396
Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L417-26
20008115
Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L901-10
19304909
Am J Physiol. 1996 Feb;270(2 Pt 1):L289-97
8779999
J Biol Chem. 2005 Oct 21;280(42):35751-9
16087672
Am J Respir Cell Mol Biol. 2008 Aug;39(2):190-7
18367727
J Physiol. 2007 Apr 15;580(Pt. 2):577-92
17317749
Respir Physiol Neurobiol. 2007 Dec 15;159(3):350-9
17604701
Am J Respir Cell Mol Biol. 2007 Jun;36(6):688-96
17290033
J Biol Chem. 2010 Feb 12;285(7):4278-90
19996317
Am J Physiol. 1990 Apr;258(4 Pt 1):L134-47
2185652
Science. 1995 Aug 11;269(5225):847-50
7543698
Am J Physiol. 1998 Sep;275(3):L478-90
9728042
Curr Opin Pharmacol. 2009 Jun;9(3):262-7
19285919
Am J Respir Crit Care Med. 2006 Aug 1;174(3):299-305
16645176
J Biol Chem. 2004 May 28;279(22):23183-92
15047694
J Biol Chem. 2008 Sep 26;283(39):26805-19
18662982
J Biol Chem. 2006 Aug 11;281(32):22992-3002
16754672
Am J Physiol. 1998 Dec;275(6):L1127-33
9843850
J Clin Invest. 1989 Nov;84(5):1424-31
2478586
Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L242-9
16143588
J Biol Chem. 2005 Mar 18;280(11):10202-9
15647273
Am J Physiol. 1989 Jul;257(1 Pt 1):C129-40
2473651
Respirology. 2006 Jan;11 Suppl:S12-5
16423262
FASEB J. 2004 May;18(7):875-7
15001557
Am J Respir Cell Mol Biol. 2003 Jul;29(1):81-7
12600831
J Gen Physiol. 2006 May;127(5):591-604
16636206
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8418-22
7667305
Am J Physiol. 1996 Apr;270(4 Pt 1):L487-503
8928808
J Biol Chem. 2005 May 6;280(18):17798-806
15746099
Am J Physiol Lung Cell Mol Physiol. 2002 Apr;282(4):L599-608
11880284
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):189-201
18585484
J Clin Invest. 1986 Nov;78(5):1245-52
3771796
J Gen Physiol. 2002 Feb;119(2):199-207
11815669
Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L14-24
10893198
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4083-8
17360481
J Clin Invest. 1998 Jun 15;101(12):2741-50
9637708
Annu Rev Physiol. 2009;71:403-23
18831683
Am J Respir Cell Mol Biol. 1995 Jan;12(1):27-32
7811468
Respir Physiol Neurobiol. 2007 Dec 15;159(3):283-300
17689299
Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1207-19
16891388
Pflugers Arch. 2009 Apr;457(6):1373-80
19002711
Respir Physiol. 1991 Aug;85(2):245-56
1947462
EMBO Rep. 2001 Nov;2(11):1047-51
11606421
J Clin Invest. 1998 Oct 1;102(7):1421-30
9769335
Science. 1996 Mar 29;271(5257):1876-9
8596959
Proc Am Thorac Soc. 2004;1(1):10-6
16113405
Am J Physiol Lung Cell Mol Physiol. 2009 Sep;297(3):L439-54
19542245
Proc Am Thorac Soc. 2005;2(3):206-13
16222039
Clin Perinatol. 1999 Sep;26(3):585-99
10494466
Toxicol Appl Pharmacol. 1988 May;93(3):472-83
3285521
J Cyst Fibros. 2004 Aug;3 Suppl 2:135-9
15463946
Am J Physiol. 1995 Mar;268(3 Pt 1):G505-13
7534995